These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 16118277)
1. Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines. Hoffmann E; Lipatov AS; Webby RJ; Govorkova EA; Webster RG Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12915-20. PubMed ID: 16118277 [TBL] [Abstract][Full Text] [Related]
2. Hemagglutinin amino acids related to receptor specificity could affect the protection efficacy of H5N1 and H7N9 avian influenza virus vaccines in mice. Xu L; Bao L; Lau SY; Wu WL; Yuan J; Gu S; Li F; Lv Q; Xu Y; Pushko P; Chen H; Qin C Vaccine; 2016 May; 34(23):2627-33. PubMed ID: 27083426 [TBL] [Abstract][Full Text] [Related]
3. H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine. Khurana S; Coyle EM; Verma S; King LR; Manischewitz J; Crevar CJ; Carter DM; Ross TM; Golding H Vaccine; 2014 Nov; 32(48):6421-32. PubMed ID: 25284811 [TBL] [Abstract][Full Text] [Related]
4. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses. Mahmood K; Bright RA; Mytle N; Carter DM; Crevar CJ; Achenbach JE; Heaton PM; Tumpey TM; Ross TM Vaccine; 2008 Oct; 26(42):5393-9. PubMed ID: 18706956 [TBL] [Abstract][Full Text] [Related]
5. Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge. Wang SH; Smith D; Cao Z; Chen J; Acosta H; Chichester JA; Yusibov V; Streatfield SJ; Fattom A; Baker JR Vaccine; 2019 Mar; 37(12):1591-1600. PubMed ID: 30795941 [TBL] [Abstract][Full Text] [Related]
6. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses. Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350 [TBL] [Abstract][Full Text] [Related]
7. Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections. Liu G; Song L; Reiserova L; Trivedi U; Li H; Liu X; Noah D; Hou F; Weaver B; Tussey L Vaccine; 2012 Nov; 30(48):6833-8. PubMed ID: 23000130 [TBL] [Abstract][Full Text] [Related]
8. Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses. Wang X; Ilyushina NA; Lugovtsev VY; Bovin NV; Couzens LK; Gao J; Donnelly RP; Eichelberger MC; Wan H J Virol; 2017 Jan; 91(2):. PubMed ID: 27807224 [TBL] [Abstract][Full Text] [Related]
9. Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge. Major D; Chichester JA; Pathirana RD; Guilfoyle K; Shoji Y; Guzman CA; Yusibov V; Cox RJ Hum Vaccin Immunother; 2015; 11(5):1235-43. PubMed ID: 25714901 [TBL] [Abstract][Full Text] [Related]
10. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants. Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710 [TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens. Jadhao SJ; Lee CW; Sylte M; Suarez DL Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695 [TBL] [Abstract][Full Text] [Related]
12. Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets. Khurana S; Verma S; Verma N; Crevar CJ; Carter DM; Manischewitz J; King LR; Ross TM; Golding H J Virol; 2011 Feb; 85(3):1246-56. PubMed ID: 21084473 [TBL] [Abstract][Full Text] [Related]